Following TrxR2 inhibition by auranofin, Trx2, turned to a more oxidized form19, 20, 28, 29, and this condition is particularly evident when CsA is present together with AF (Fig. 2B, lane f). The gene discussed is TXN2; the disease is atrial fibrillation.